Our Pharmacy Department continues to monitor and manage nationwide drug shortages. Below are key updates and strategies to support safe, effective patient care.
Acute care pharmacy drug supply updates
| Medication |
Current Status |
Mitigation Strategy |
| Meperidine (injectable) |
- Product unavailable; reliable resupply not expected until the end of the year.
- Network supply likely to be exhausted despite conservation efforts.
|
- Consider non-pharmacological interventions first.
- Conserve remaining supply; limit use to essential cases.
- Consider alternative therapies.
- Starting Sept. 30: Pharmacy will centralize remaining stock; Epic alternative screen updated to prevent continued orders.
|
| Lorazepam (injectable) |
- Intermittent availability due to manufacturing delays.
|
- Epic alternative screen active; recommends oral lorazepam tablets.
|
| Dronabinol (oral capsules) |
- Unavailable; next release TBD.
|
- Epic alternative screen active; recommends megestrol suspension and prevents continued orders.
|
| Bicillin L-A (penicillin G benzathine, injectable) |
- Intermittent availability; unable to meet demand due to manufacturing delays.
|
- Epic alternative screen active; allows continued use only for pregnant patients and infants per CDC guidelines.
|
Stay informed
For a full list of products affected by current supply constraints and additional details, visit the Acute Care Pharmacy – Drug Shortage Update page on HonorHub.
For questions, contact the Pharmaceutical Supply Chain Department at hhpharmacySCteam@honorhealth.com.
